| 摘要 |
Disclosed herein are compounds of formula (I) that may be specific to PPAR and/or EGF receptors, and methods of making and using same, wherein X is C-Calkylene, optionally substituted with one, two or three substituents selected from halogen or hydroxyl; R is selected from the group consisting of C-Calkyl, C-Ccycloalkyl, C-Calkenyl, and C-Calkynyl; R is selected from the group consisting of hydrogen and C-Calkyl; R is independently selected, for each occurrence from the group consisting of hydrogen, C-Calkoxy, C-Calkyl, cyano, CCcycloalkyl, halogen, hydroxyl, and nitro; R is selected from the group consisting of hydrogen and C-Calkyl; R is hydrogen C-Calkyl; or pharmaceutically acceptable salts or N-oxides thereof. |
